SIRT1 activation influences downstream targets, manages oxidative stress, delivers neuroprotective and anti‐neuroinflammatory outcomes, and thus stands out as a vital modulator of AD pathogenesis.[47] A key downstream target of SIRT1 is STAT3, which undergoes deacetylation via SIRT1‐mediated modulation. Here, STAT3 is linked to Alzheimer disease.